ArticleCureus2025
Prevalence of Osteoporosis and Osteopenia in Patients With Type 2 Diabetes at King Abdulaziz University Hospital: A Retrospective Analysis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Comparison of Bone Microarchitecture and Clinical Biomarkers between Diabetic and Non-Diabetic Postmenopausal Osteoporotic Women.Journal of bone metabolism · 2026Article
- Cellular signaling crosstalk between osteoporosis and diabetes: Common mechanisms and therapeutic targets (Review).Biomedical reports · 2026Review
- Osteoporosis evidence landscape to inform policy and practice: A comprehensive scoping review.Journal of family medicine and primary care · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Osteoporosis mainly affects postmenopausal women and is characterized by decreasing bone mass and an increased risk of fracture. As populations age, it becomes more common and is frequently missed until fractures happen. Simultaneously, there is conflicting evidence about the relationship between bone health and diabetes, a chronic metabolic illness, with varying effects on the skeletal system. In light of the rising incidence of both disorders, this study examines the relationship between diabetes and osteoporosis/osteopenia in patients at King Abdulaziz University Hospital (KAUH), Jeddah, Saudi Arabia. Methods At KAUH, Jeddah, a retrospective study on 423 type 2 diabetes patients (2011-2021) was conducted, analyzing clinical outcomes, including BMI and blood glucose levels, using IBM SPSS Statistics for Windows, Version 23 (Released 2015; IBM Corp., Armonk, NY, USA). Ethical approval was granted by the Institutional Review Board, ensuring compliance with Good Clinical Practice (GCP) Guidelines. Results In this study, 423 diabetic patients with an average body mass index (BMI) of 29.12 kg/m² and ages ranging from 24 to 104 years (mean, 63.67) were primarily male, with 216 patients accounting for 51.1%. A total of 227 patients (53.7%) were aged 60-79 years. Most participants, 400 patients (94.6%), had average bone mineral density (BMD), while 161 patients (38.1%) were classified as obese. Among those with abnormal BMD, 23 patients (5.4%); 12 (2.8%) were identified as having osteopenia, and 11 (2.6%) were diagnosed with osteoporosis. Glycemic management and bone health indicators were examined in the lab, along with comprehensive BMD and T/Z scores. Conclusion This study enhances our understanding of the relationship between type 2 diabetes and bone health, emphasizing the importance of individualized evaluations for high-risk populations. Further research is needed to explore the complex interplay between diabetes, bone health, and demographic factors, to inform more effective preventive and therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.